Carrick Therapeutics, Inc.
Carrick Therapeutics is a clinical-stage biopharmaceutical company focused on building novel oncology therapies for patients with aggressive and resistant cancers including breast, prostate, ovarian, pancreatic, and Ewing's sarcoma. The company translates in-house and in-licensed assets through a network of pharma partners, clinicians, and research institutions. Corporate headquarters is in Boston, Massachusetts.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountDec 2022
Dec 2022
Jun 2021
Jun 2021
Oct 2016
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
